(Reuters) - The Cambridge, Massachusetts-based biotechnology company said net earnings rose to $139.9 million, or 51 cents a share, from $134.5 million, or 49 cents a share, a year before.
Excluding one-time items, the company posted a profit of 88 cents a share. Analysts had expected earnings of 81 cents a share.
Read more at Reuters.com Market News
Excluding one-time items, the company posted a profit of 88 cents a share. Analysts had expected earnings of 81 cents a share.
Read more at Reuters.com Market News
No comments:
Post a Comment